Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study (Q43281253)

18 November 2017

Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study (English)

1 reference

18 November 2017

1 reference

6

Eleanor Berrie

1 reference

18 November 2017

5

Prudence Bird

1 reference

18 November 2017

4

Geoff Hale

1 reference

18 November 2017

15

Malcolm K Brenner

1 reference

18 November 2017

12

Andrew R Gennery

1 reference

18 November 2017

Karin C Straathof

1

1 reference

18 November 2017

Kanchan Rao

2

1 reference

18 November 2017

Matthias Eyrich

3

1 reference

18 November 2017

Lucinda Brown

7

1 reference

18 November 2017

Stuart Adams

8

1 reference

18 November 2017

Paul G Schlegel

9

1 reference

18 November 2017

Nicholas Goulden

10

1 reference

18 November 2017

H Bobby Gaspar

11

1 reference

18 November 2017

Paul Landais

13

1 reference

18 November 2017

E G Davies

14

1 reference

18 November 2017

Paul A Veys

16

1 reference

18 November 2017

Persis Jal Amrolia

17

1 reference

18 November 2017

language of work or name

English

0 references

publication date

2 September 2009

1 reference

18 November 2017

1 reference

18 November 2017

374

1 reference

18 November 2017

912-920

1 reference

18 November 2017

9693

1 reference

Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99

18 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

Unusual complications after bone marrow transplantation for dyskeratosis congenita

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

In vivo depletion of hematopoietic stem cells in the rat by an anti-CD45 (RT7) antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

Anti-CD45-mediated cytoreduction to facilitate allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

Hematopoietic and immunomodulatory effects of lytic CD45 monoclonal antibodies in patients with hematologic malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

Changes in thymic function with age and during the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

A Prospective Multicenter Trial of Peripheral Blood Stem Cell Sibling Allografts for Acute Myeloid Leukemia in First Complete Remission Using Fludarabine-Cyclophosphamide Reduced Intensity Conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

THERAPEUTIC POTENTIAL OF MONOCLONAL ANTIBODIES TO THE LEUKOCYTE-COMMON ANTIGEN

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

Blocking of cytotoxic T cell function by monoclonal antibodies against the CD45 antigen (T200/leukocyte-common antigen)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960945-4

7 January 2021

10.1016/S0140-6736(09)60945-4

Identifiers

DOI

1 reference

18 November 2017

1 reference